1. Home
  2. OPRT vs LAB Comparison

OPRT vs LAB Comparison

Compare OPRT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oportun Financial Corporation

OPRT

Oportun Financial Corporation

HOLD

Current Price

$8.13

Market Cap

275.7M

Sector

Finance

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.68

Market Cap

326.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRT
LAB
Founded
2005
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
275.7M
326.2M
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
OPRT
LAB
Price
$8.13
$0.68
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$7.00
$1.35
AVG Volume (30 Days)
296.5K
1.6M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
127.18
61.54
EPS
0.22
0.26
Revenue
$956,685,000.00
$101,937,000.00
Revenue This Year
$32.79
N/A
Revenue Next Year
$4.47
$2.63
P/E Ratio
$35.77
$2.64
Revenue Growth
N/A
N/A
52 Week Low
$4.03
$0.63
52 Week High
$8.30
$1.72

Technical Indicators

Market Signals
Indicator
OPRT
LAB
Relative Strength Index (RSI) 68.31 42.55
Support Level $4.89 $0.63
Resistance Level $8.30 $1.02
Average True Range (ATR) 0.30 0.04
MACD -0.01 0.01
Stochastic Oscillator 96.30 53.06

Price Performance

Historical Comparison
OPRT
LAB

About OPRT Oportun Financial Corporation

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: